Jean-selim Driouich
Marseille, 13005, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.
Journal: The Journal of antimicrobial chemotherapy
Published: February 15, 2026
Preclinical efficacy of a favipiravir and nitazoxanide combination against Rift Valley Fever Virus.
Journal: Antiviral research
Published: January 27, 2026
Modulating Chikungunya and Mayaro virus-induced disease severity in mice using low concentrations of anti-IFNAR1 antibodies.
Journal: Emerging microbes & infections
Published: January 14, 2026
De novo generation of viruses in animals: from infection models to vaccine development.
Journal: mSphere
Published: August 11, 2025
Virological characterization of SARS-CoV-2 BA.2.86 variants by assessing antiviral susceptibility, in vivo infectivity and replicative fitness.
Journal: Scientific reports
Published: June 24, 2025
Persistence of Oropouche virus in body fluids among imported cases in France, 2024.
Journal: The Lancet. Infectious diseases
Published: November 20, 2024
In vivo rescue of arboviruses directly from subgenomic DNA fragments.
Journal: Emerging microbes & infections
Published: May 14, 2024
Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns.
Journal: Heliyon
Published: January 09, 2024
Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 05, 2023
Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains.
Journal: Antiviral research
Published: November 28, 2023
Last Updated: 09/26/2026